Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid
2016/08/11 by Nicolette Mary Heinsinger, Nicolette M. Heinsinger, Mariam Alexandra Gachechiladze +2 · 25 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Alzheimer's disease research and treatments #Diabetes, Cardiovascular Risks, and Lipoproteins #Peroxisome Proliferator-Activated Receptors
paper · doi:10.1093/jnen/nlw067
Abstract
Apolipoprotein E (apoE) is associated with lipoproteins in the cerebrospinal fluid (CSF). APOE4 increases and APOE2 decreases the risk for Alzheimer disease (AD) compared to the risk associated with APOE3 Because apoE4 is less efficient at cholesterol efflux than apoE2 or apoE3 in vitro, we hypothesized that APOE genotype may affect apoE particle size in vivo and that these size differences may be related to AD risk. We used nondenaturing gel electrophoresis to test for differences in the size of apoE complexes in human CSF samples of various APOE genotypes and created profiles of each sample to compare the patterns of apoE distribution. For middle-aged adults with no dementia, APOE 2.3 individuals had significantly larger apoE complexes than APOE 3.3 subjects, who had significantly larger apoE complexes than APOE 3.4 and APOE 4.4 individuals. Similarly, in an independent cohort of older adults, CSF apoE complexes of APOE4-positive individuals were smaller than those of the APOE4-negative individuals. Compared to individuals with no dementia, those with the mildest stages of dementia had similar sized CSF apoE complexes. These results identify a novel phenotypic difference in the size of CSF apoE complexes in middle age that correlate with the risk of AD later in life.
Cited by
- DHA brain uptake and APOE4 status: a PET study with [1- 11 C]-DHA. [europepmc]
- Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention. [europepmc]
- High-density lipoprotein mimetic peptide 4F mitigates amyloid-β-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia. [europepmc]
- Apolipoprotein E4 Alters Astrocyte Fatty Acid Metabolism and Lipid Droplet Formation. [europepmc]
- ApoE4: an emerging therapeutic target for Alzheimer's disease. [europepmc]
- Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier. [europepmc]
- Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk. [europepmc]
- Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. [europepmc]
- O-glycosylation on cerebrospinal fluid and plasma apolipoprotein E differs in the lipid-binding domain. [europepmc]
- ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes. [europepmc]
- APOE in the normal brain. [europepmc]
- Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease. [europepmc]
- Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How. [europepmc]
- Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer's Disease. [europepmc]
- ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease. [europepmc]
- APOE2: protective mechanism and therapeutic implications for Alzheimer's disease. [europepmc]
- Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis. [europepmc]
- HDL Proteome and Alzheimer's Disease: Evidence of a Link. [europepmc]
- APOE and Alzheimer's Disease: From Lipid Transport to Physiopathology and Therapeutics. [europepmc]
- Cholesterol and Alzheimer's Disease; From Risk Genes to Pathological Effects. [europepmc]
- Tau Protein Interaction Partners and Their Roles in Alzheimer's Disease and Other Tauopathies. [europepmc]
- Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise. [europepmc]
- ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias. [europepmc]
- Lipoproteins in the Central Nervous System: From Biology to Pathobiology. [europepmc]
- Apolipoprotein E in lipid metabolism and neurodegenerative disease. [europepmc]
Related